Treating Alpelisib-Induced Hyperglycemia with Very Low Carbohydrate Diets and Sodium-Glucose Co-Transporter 2 Inhibitors: A Case Series

Treating Alpelisib-Induced Hyperglycemia with Very Low Carbohydrate Diets and Sodium-Glucose Co-Transporter 2 Inhibitors: A Case Series

Alpelisib is a α-selective phosphatidylinositol 3-kinase (PI3K) inhibitor approved for treatment of postmenopausal women, and men, with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2–), PIK3CA-mutated, advanced breast cancer (ABC). Hyperglycemia is a common,...

Full description

Bibliographic Details
Main Authors: Tahj Blow BS, Parker N. Hyde PhD, John N. Falcone MD, Aaron Neinstein MD, Neil Vasan MD, PhD, Ritika Chitkara MPAS, Maurice A. Hurd BA, Sagar Sardesai MBBS, Maryam B. Lustberg MD, MPH, James H. Flory MD, MSCE, Jeff S. Volek PhD, Marcus D. Goncalves MD, PhD
Format: Article
Language:English
Published: SAGE Publishing 2021-07-01
Series:Integrative Cancer Therapies
Online Access:https://doi.org/10.1177/15347354211032283

Internet

https://doi.org/10.1177/15347354211032283

Similar Items